Trials / Conditions / Hyperprolactinemia

Hyperprolactinemia

26 registered clinical trials studyying Hyperprolactinemia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets NCT07124221	Changchun GeneScience Pharmaceutical Co., Ltd.	Phase 3
Active Not Recruiting	A Study on Bioequivalence of Cabergoline Tablets in Human Body NCT07008417	Changchun GeneScience Pharmaceutical Co., Ltd.	Phase 1
Active Not Recruiting	PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics NCT05033119	Ulla Schierup Nielsen	—
Terminated	Hyperprolactinemia and Adrenal Steroidogenesis NCT04146389	Insel Gruppe AG, University Hospital Bern	—
Completed	Prevalence of Hyperprolactinemia in Systemic Scleroderma NCT04746313	University Hospital, Lille	—
Unknown	Effectiveness and Safety of Bushen Culuan Decoction for Anovulatory Infertility NCT03709849	Xiyuan Hospital of China Academy of Chinese Medical Sciences	Phase 2
Unknown	Develop and Implement Methods for Diagnostic and Treatment of Hormonal Disorders in Patients With Chronic Kidn NCT04439747	Belarusian State Medical University	—
Completed	Administration of Kisspeptin in Patients With Hyperprolactinemia NCT02956447	Massachusetts General Hospital	Phase 2
Completed	Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire NCT03569787	University Hospitals Coventry and Warwickshire NHS Trust	—
Completed	Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole NCT03038308	Columbia University	Phase 1 / Phase 2
Suspended	Pituitary Function and Spontaneous Intracranial Hypotension NCT02603549	Cedars-Sinai Medical Center	—
Completed	Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON NCT02098668	University of Zurich	—
Unknown	A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction Fr NCT01742390	Si Tianmei	Phase 4
Completed	Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia NCT01852331	The University of Hong Kong	Phase 2
Completed	Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premeno NCT01338298	University of Maryland, Baltimore	N/A
Completed	Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE) NCT01270711	Pfizer	—
Completed	Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment NCT06326840	Taipei Medical University Hospital	N/A
Completed	Aripiprazole and Prolactin Study NCT01085383	University of Oxford	Phase 4
Completed	Kisspeptin Administration in the Adult NCT00914823	Massachusetts General Hospital	Phase 1
Terminated	The Luveris In Vitro Fertilization Trial NCT00889512	University Reproductive Associates	Phase 4
Withdrawn	Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment NCT00699530	University of Aarhus	—
Completed	Endometriosis Patients Undergoing Quinagolide Treatment NCT00625950	Instituto Valenciano de Infertilidad, IVI VALENCIA	Phase 4
Unknown	Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia NCT00541554	Genovate Biotechnology Co., Ltd.,	Phase 4
Completed	The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events NCT01052948	Pfizer	—
Unknown	Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine NCT00315081	University Hospital, Bonn	Phase 3
Completed	Characterization of Macroprolactinemia NCT00436111	Kansai Medical University	—